This investment will facilitate the company's move to a larger, advanced office facility in the Greater Toronto Area, Ontario. This new investment is part of AstraZeneca's global goal to achieve ...

Global biopharmaceutical business AstraZeneca will expand its research and development facilities in Mississauga and relocate its Canadian headquarters to a larger, state-of-the-art office. The $820 ...

Invest Ontario is partnering with AstraZeneca (AZN) to expand the company’s global R&D hub in Mississauga. This C$820M investment underscores Ontario’s growing prominence in the life sciences ...

AstraZeneca has unveiled plans to invest around ... AZ announced a C$500 million investment in its Global Clinical Hub in Mississauga, Ontario, to expand its research and clinical trials ...

The investment comes after AstraZeneca last year completed its C$3 billion acquisition of Hamilton, Ontario-based Fusion Pharmaceuticals, which is developing next-generation radioconjugates ...

Invest Ontario added that it also provided AstraZeneca with site selection services, market intelligence, and immigration support to streamline the investment process. “This investment is a reflection ...

MISSISSAUGA — The Ontario government has secured a $820 million investment from AstraZeneca, a global biopharmaceutical business, to expand the company’s research and development (R&D) facilities in ...